GlassScriptPhysician profile
Shaun Hajjari
NPI 1154809887
$2,735.68
in general payments reported to CMS, 2019-2025
20 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.81 · 2020: $23.73 · 2021: $316 · 2022: $220 · 2023: $154 · 2024: $895 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,151.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $343.69 | 2019-2025 | Simbrinza, Rocklatan, Rhopressa |
| Tarsus Pharmaceuticals, INC. | $342.95 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $320.56 | 2024-2025 | Vevye |
| Ani Pharmaceuticals, INC. | $299.68 | 2024-2025 | Purified Cortrophin Gel |
| Dompe US, INC. | $289.60 | 2021-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $249.59 | 2024-2025 | Miebo, Xiidra, Ic-8 Apthera Iol |
| Novartis Pharmaceuticals Corporation | $154.83 | 2021-2023 | |
| Abbvie INC. | $142.97 | 2022-2024 | |
| Kala Pharmaceuticals, INC. | $105.14 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $99.24 | 2025 | Catalys System, Tecnis Iol |
| Oyster Point Pharma, INC. | $70.71 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $60.16 | 2024-2025 | Idosetr, Istent Infinite, Idose |
| Amgen INC. | $40.99 | 2024 | Tepezza |
| Mallinckrodt Hospital Products INC. | $37.89 | 2024 | Acthar |
| Apellis Pharmaceuticals, INC. | $34.96 | 2025 | Syfovre |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $33.60 | 2021 | |
| Rxsight INC | $33.48 | 2022-2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Light Adjustable Lens (Rxlal) |
| Allergan, INC. | $32.28 | 2021 | |
| Biogen, INC. | $23.73 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $19.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Hajjari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.